|
|
|
|
Eric Schmidt founded Cambridge Consultants, Inc.
He is Chief Financial Officer for Allogene Therapeutics, Inc. Dr. Schmidt is also on the board of Relmada Therapeutics, Inc. and Revolution Medicines, Inc.
He previously occupied the position of Vice President of UBS Securities LLC and Managing Director at Cowen & Co. LLC.
Dr. Schmidt received an undergraduate degree from the University of Pennsylvania and a doctorate from Massachusetts Institute of Technology.
|
| Aktuelle Stellungen und Verantwortungsbereiche Eric Schmidt | |
|
|
| Eric Schmidt: Persönliches Netzwerk | |
|
| Name | Verbundene Unternehmen |
| Charles J. Casamento | Relmada Therapeutics, Inc. |
| Mark A. Goldsmith | Revolution Medicines, Inc. |
| Margaret A. Horn | Revolution Medicines, Inc. |
| Sergio Traversa | Relmada Therapeutics, Inc. |
| Alexis Borisy | Revolution Medicines, Inc. |
| Peter Svennilson | Revolution Medicines, Inc. |
| Maged S. Shenouda | Relmada Therapeutics, Inc. |
| Neil Exter | Revolution Medicines, Inc. |
| Stephen M. Kelsey | Revolution Medicines, Inc. |
| Luan M. Wilfong | Revolution Medicines, Inc. |
|
© 2021 People and Ownership : 
|
|
|
| Eric Schmidt : Verbindungen | |
|
|
|
Canada
España
France
Italia
Schweiz (DE)
United Kingdom
United States
